ÖZET
Akromegali, büyüme hormonu (BH) üreten hipofiz adenomuna bağlı olarak patolojik olarak artmış BH ve insülin benzeri büyüme faktörü-1 seviyelerinin söz konusu olduğu kronik bir endokrinopatidir. Akromegalinin kısmen geri dönüşümsüz komplikasyonlarından biri, bu hastalarda ciddi bir morbidite ile ilişkilendirilen artropatidir. Eklem ilişkili şikayetler ağrı, sertlik veya fonksiyonel kısıtlılık gibi, genellikle erken yaşlarda tipik radyolojik anormalliklerle kendisini gösterir. Burada non-travmatik spontan sağ rektus femoris kas rüptürü ve eşlik eden kas içi hematomu olan 24 yaşında akromegalik bir erkek olguyu sunmaktayız.
References
1
Katznelson L, Laws ER Jr, Melmed S, Molitch ME, Murad MH, Utz A, et al. Acromegaly: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 2014;99:3933-51.
2
Forgacs SS. Acromegaly: In: Hochberg MC, Silman AJ, Smolen JS, Weinblatt ME, Weisman MH, editors. Rheumatology. 3rd ed. Philadelphia: Mosby; 2003. p. 1967-72.
3
Colao A, Ferone D, Marzullo P, Lombardi G. Systemic complications of acromegaly: epidemiology, pathogenesis, and management. Endocr Rev 2004;25:102-52.
4
Ben-Shlomo A, Melmed S. Acromegaly. Endocrinol Metab Clin North Am 2001;30:565-83.
5
Marie P. Sur deux cas d’acromegalie. Rev Med 1886;6:297-9.
6
Reid TJ, Post KD, Bruce JN, Nabi Kanibir M, Reyes-Vidal CM, Freda PU. Features at diagnosis of 324 patients with acromegaly did not change from 1981 to 2006: acromegaly remains under-recognized and under-diagnosed. Clin Endocrinol (Oxf) 2010;72:203-8.
7
Colao A, Pivonello R, Scarpa R, Vallone G, Ruosi C, Lombardi G. The acromegalic arthropathy. J Endocrinol Invest 2005;28(8 Suppl):24-31.
8
Tagliafico A, Resmini E, Ferone D, Martinoli C. Musculoskeletal complications of acromegaly: what radiologists should know about early manifestations. Radiol Med 2011;116:781-92.
9
Biermasz NR, Pereira AM, Smit JW, Romijn JA, Roelfsema F. Morbidity after long-term remission for acromegaly: persisting joint-related complaints cause reduced quality of life. J Clin Endocrinol Metab 2005;90:2731-9.
10
Killinger Z, Payer J, Lazúrová I, Imrich R, Homérová Z, Kužma M, et al. Arthropathy in acromegaly. Rheum Dis Clin North Am 2010;36:713-20.
11
Wu JC, Huang WC, Chang HK, Ko CC, Lirng JF, Chen YC. Natural history of acromegaly: incidences, re-operations, cancers, and mortality rates in a national cohort. Neuroendocrinology 2020;110:977-87.
12
Wassenaar MJ, Biermasz NR, Bijsterbosch J, Pereira AM, Meulenbelt I, Smit JW, et al. Arthropathy in long-term cured acromegaly is characterised by osteophytes without joint space narrowing: a comparison with generalised osteoarthritis. Ann Rheum Dis 2011;70:320-5.
13
Wassenaar MJ, Biermasz NR, van Duinen N, van der Klaauw AA, Pereira AM, Roelfsema F, et al. High prevalence of arthropathy, according to the definitions of radiological and clinical osteoarthritis, in patients with long-term cure of acromegaly: a case-control study. Eur J Endocrinol 2009;160:357-65.
14
Colao A, Marzullo P, Vallone G, Marinò V, Annecchino M, Ferone D, et al. Reversibility of joint thickening in acromegalic patients: an ultrasonography study. J Clin Endocrinol Metab 1998;83:2121-5.
15
Glick R, Epstein DS, Aponso DT. Spontaneous bilateral quadriceps tendon rupture associated with norfloxacin. Intern Med J 2015;45:1313-5.
16
Carlton SM, Du J, Davidson E, Zhou S, Coggeshall RE. Somatostatin receptors on peripheral primary afferent terminals: inhibition of sensitized nociceptors. Pain 2001;90:233-44.
